{"ATC Code":"N06BA07","Abbreviation":"","Aliases":["Modafinil","modafinil","2-(Benzhydrylsulfinyl)acetamide","modaphonil","Modafinilo","Modafinilum","Modafinil civ","CEP 1538","CEP-1538","Acetamide, 2-((diphenylmethyl)sulfinyl)-","Thn102 component modafinil","DEP-1538","Thn-102 component modafinil","CRC-40476","N06BA07","(rs)-2-(diphenylmethylsulfinyl)acetamide","rac-2-((diphenylmethyl)sulfinyl)acetamide","Provigil","Modiodal","2-[(diphenylmethyl)sulfinyl]acetamide","CRL 40476","Alertec","R Modafinil","CRL-40476","2-((Diphenylmethyl)sulfinyl)acetamide"],"Biological Half-Life":"23-215 hours","CAS":"68693-11-8","ChEBI":"CHEBI:31859","ChEMBL":"CHEMBL1373","ChemicalClasses":[],"Classes":["Eugeroic"],"Color/Form":"White to off-white crystalline powder","DEA no":1680,"Drug Classes":"Breast Feeding; Lactation; Milk, Human; Central Nervous System Stimulants; Wakefulness-Promoting Agents","Drug Indication":"To improve wakefulness in patients with excessive daytime sleepiness (EDS) associated with narcolepsy.","Drug Warnings":"Serious rash, including Stevens-Johnson Syndrome requiring hospitalization and discontinuation of treatment has been reported in adults and children in association with the use of modafinil. ... Rare cases of serious or life-threatening rash, including Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and Drug Rash with Eosinophilia and Systemic Symptoms have been reported in adults and children in worldwide post-marketing experience. The reporting rate of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome associated with modafinil use, which is generally accepted to be an underestimate due to underreporting, exceeds the background incidence rate. Estimates of the background incidence rate for these serious skin reactions in the general population range between 1 to 2 cases per million-person years. There are no factors that are known to predict the risk of occurrence or the severity of rash associated with modafinil. Nearly all cases of serious rash associated with modafinil occurred within 1 to 5 weeks after treatment initiation. However, isolated cases have been reported after prolonged treatment (e.g., 3 months). Accordingly, duration of therapy cannot be relied upon as a means to predict the potential risk heralded by the first appearance of a rash. Although benign rashes also occur with modafinil, it is not possible to reliably predict which rashes will prove to be serious. Accordingly, modafinil should ordinarily be discontinued at the first sign of rash, unless the rash is clearly not drug-related. Discontinuation of treatment may not prevent a rash from becoming life-threatening or permanently disabling or disfiguring.","Esters":[],"European Community (EC) Number":"640-968-7","FDA Pharmacological Classification":"R3UK8X3U3D","Formating":[],"HMDB ID":"HMDB0014883","HeavyAtomCount":19,"Human Drugs":"Breast Feeding; Lactation; Milk, Human; Central Nervous System Stimulants; Wakefulness-Promoting Agents","IUPACName":"2-benzhydrylsulfinylacetamide","InChI":"InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)","InChIKey":"YFGHCGITMMYXAQ-UHFFFAOYSA-N","MeSH Pharmacological Classification":"Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP3A. (See all compounds classified as Cytochrome P-450 CYP3A Inducers.)","Melting Point":"164-166 °C","MolecularFormula":"C\u003csub\u003e15\u003c/sub\u003eH\u003csub\u003e15\u003c/sub\u003eNO\u003csub\u003e2\u003c/sub\u003eS","MolecularWeight":"273.4 g/mol","Pharmacodynamics":"Modafinil is a stimulant drug marketed as a 'wakefulness promoting agent' and is one of the stimulants used in the treatment of narcolepsy. Narcolepsy is caused by dysfunction of a family of wakefulness-promoting and sleep-suppressing peptides, the orexins, whose neurons are activated by modafinil. The prexin neuron activation is associated with psychoactivation and euphoria. Modafinil is not indicated for complaints of lack of energy or fatigue; but it appears to be very helpful for some patients. Also, it has been used in the treatment of hypersomnia, a disorder in which patients lack the capacity for meaningful sleep and may require ten or more hours per day. Recent studies have have found that modafinil may help recovering cocaine addicts fight their addiction.","Physical Description":"Solid","PubChemId":4236,"RefCount":2,"RefCur":"","References":[{"Name":"Wikipedia","Urls":[{"Link":"https://en.wikipedia.org/wiki/Modafinil","Name":"Modafinil","Sub":false}]},{"Name":"Wikidata","Urls":[{"Link":"https://www.wikidata.org/wiki/Q410441","Name":"Modafinil","Sub":false}]},{"Name":"DrugBank","Urls":[{"Link":"https://go.drugbank.com/drugs/DB00745","Name":"Modafinil","Sub":false}]},{"Name":"PubChem","Urls":[{"Link":"https://pubchem.ncbi.nlm.nih.gov/compound/4236","Name":"Modafinil","Sub":false}]},{"Name":"ChEMBL","Urls":[{"Link":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1373","Name":"Modafinil","Sub":false}]},{"Name":"ChEBI","Urls":[{"Link":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:31859","Name":"Modafinil","Sub":false}]},{"Name":"Common Chemistry","Urls":[{"Link":"https://commonchemistry.cas.org/detail?cas_rn=68693-11-8","Name":"Modafinil","Sub":false}]},{"Name":"HMDB","Urls":[{"Link":"https://hmdb.ca/metabolites/HMDB0014883","Name":"Modafinil","Sub":false}]},{"Name":"KEGG","Urls":[{"Link":"https://www.kegg.jp/entry/D01832","Name":"Modafinil","Sub":false}]},{"Name":"UNII","Urls":[{"Link":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/R3UK8X3U3D","Name":"Modafinil","Sub":false}]},{"Name":"EPA DSSTox","Urls":[{"Link":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID0023329","Name":"Modafinil","Sub":false}]}],"Refs":["National Center for Biotechnology Information. PubChem Compound Summary for CID 4236, Modafinil. Accessed July 7, 2025. \u003ca href=https://pubchem.ncbi.nlm.nih.gov/compound/4236\u003ehttps://pubchem.ncbi.nlm.nih.gov/compound/4236\u003c/a\u003e"],"SMILES":"C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N","SaltData":[],"Salts":[],"Solubility":"Slightly soluble","StereoisomerData":[{"Aliases":["Modafinil, (+)-","Modafinil, (S)-","2-[(S)-(Diphenylmethyl)sulfinyl]acetamide","2-((S)-(diphenylmethyl)sulfinyl)acetamide","807-091-3","(S)-Modafinil","(S)-(+)-Modafinil","Acetamide, 2-((S)-(diphenylmethyl)sulfinyl)-","CRL 40983","NH 02D","NH-02D","CRL-40983","2-[(S)-(Diphenylmethyl)sulfinyl]acetamide;(+)-Modafinil;(S)-(+)-Modafinil"],"PubChemId":11173366,"SMILES":"C1=CC=C(C=C1)C(C2=CC=CC=C2)[S@@](=O)CC(=O)N","Structure":"\u003csvg  preserveAspectRatio=\"none\" style=\"display:block\" viewBox=\"0 0 102.742 78.285\"\u003e\u003crect width=\"100%\" height=\"100%\" fill=\"#fff\"/\u003e\u003cdesc\u003eGenerated by the Chemistry Development Kit (http://github.com/cdk)\u003c/desc\u003e\u003cg fill=\"#3050f8\" stroke=\"#000\" stroke-linecap=\"round\" stroke-linejoin=\"round\" stroke-width=\".7\"\u003e\u003cpath fill=\"#fff\" stroke=\"none\" d=\"M0 0h103v79H0z\"/\u003e\u003cg class=\"mol\"\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m53.846 8.658-13.208-7.62M51.407 10.066 40.638 3.853\"/\u003e\u003c/g\u003e\u003cpath d=\"M53.846 8.658v15.24\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m40.638 31.518 13.208-7.62M40.638 28.703l10.769-6.213\"/\u003e\u003c/g\u003e\u003cpath d=\"m40.638 31.518-13.208-7.62\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"M27.43 8.658v15.24M29.868 10.066V22.49\"/\u003e\u003c/g\u003e\u003cpath d=\"M40.638 1.038 27.43 8.658M40.638 31.518v15.24M40.638 46.758l-13.198 7.62\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"M27.44 54.378 14.236 46.75M25.002 55.786l-10.766-6.22\"/\u003e\u003c/g\u003e\u003cpath d=\"M14.236 46.75 1.038 54.37\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m1.038 54.37.005 15.248M3.477 55.777l.004 12.434\"/\u003e\u003c/g\u003e\u003cpath d=\"m1.043 69.618 13.203 7.629\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m14.246 77.247 13.198-7.62M14.247 74.431l10.759-6.212\"/\u003e\u003c/g\u003e\u003cpath d=\"m27.44 54.378.004 15.249M40.638 46.758l10.486 6.054\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"M55.055 58.296v7.401M52.617 58.296v7.401\"/\u003e\u003cpath stroke=\"#c6c62c\" d=\"M55.055 58.296v3.7\" class=\"hi\"/\u003e\u003cpath stroke=\"#ff0d0d\" d=\"M55.055 65.697v-3.701\" class=\"hi\"/\u003e\u003cpath stroke=\"#c6c62c\" d=\"M52.617 58.296v3.7\" class=\"hi\"/\u003e\u003cpath stroke=\"#ff0d0d\" d=\"M52.617 65.697v-3.701\" class=\"hi\"/\u003e\u003c/g\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m58.343 52.626-1.472-.85\"/\u003e\u003cpath stroke=\"#c6c62c\" d=\"m60.445 51.662-1.905-1.1M62.547 50.699l-2.338-1.35M64.649 49.735l-2.772-1.6M66.751 48.772l-3.205-1.85M68.853 47.808l-3.638-2.1\"/\u003e\u003c/g\u003e\u003cpath d=\"m67.034 46.758 13.198 7.62\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"M81.452 53.674v12.023M79.013 53.674v12.023\"/\u003e\u003cpath stroke=\"#ff0d0d\" d=\"M81.452 65.697v-6.011M79.013 65.697v-6.011\" class=\"hi\"/\u003e\u003c/g\u003e\u003cpath d=\"m80.232 54.378 10.045-5.799\" class=\"bond\"/\u003e\u003cpath fill=\"#c6c62c\" stroke=\"none\" d=\"M55.381 55.515q0 .649-.476 1.018-.471.363-1.268.363-.417 0-.768-.065-.346-.06-.578-.173v-.589q.244.113.607.202.369.09.762.09.548 0 .828-.215.28-.214.28-.577 0-.238-.108-.399-.101-.167-.351-.31t-.696-.297q-.625-.227-.947-.554-.315-.333-.315-.899 0-.393.196-.667.203-.279.554-.428.357-.155.815-.155.405 0 .739.077.339.072.613.197l-.197.53q-.25-.113-.547-.185-.298-.077-.626-.077-.458 0-.69.196-.232.197-.232.518 0 .244.101.411.107.167.339.297.232.126.631.28.429.155.727.34.297.178.452.434.155.25.155.637\" class=\"atom\"/\u003e\u003cpath fill=\"#ff0d0d\" stroke=\"none\" d=\"M56.095 69.615q0 .756-.256 1.328-.256.565-.756.881-.5.315-1.244.315-.756 0-1.262-.315-.506-.316-.756-.887-.244-.572-.244-1.334 0-.75.244-1.309.25-.566.756-.882.506-.315 1.274-.315.732 0 1.232.315.5.31.756.876.256.565.256 1.327m-3.863 0q0 .923.387 1.459.392.529 1.22.529.839 0 1.22-.529.387-.536.387-1.459 0-.929-.387-1.452-.381-.524-1.208-.524-.834 0-1.226.524-.393.523-.393 1.452M82.492 69.615q0 .756-.256 1.328-.256.565-.756.881-.5.315-1.245.315-.756 0-1.262-.315-.506-.316-.756-.887-.244-.572-.244-1.334 0-.75.244-1.309.25-.566.756-.882.506-.315 1.274-.315.733 0 1.233.315.5.31.756.876.256.565.256 1.327m-3.864 0q0 .923.387 1.459.393.529 1.22.529.84 0 1.221-.529.387-.536.387-1.459 0-.929-.387-1.452-.381-.524-1.209-.524-.833 0-1.226.524-.393.523-.393 1.452\" class=\"atom\"/\u003e\u003cg stroke=\"none\" class=\"atom\"\u003e\u003cpath d=\"M95.371 49.208h-.72l-2.619-4.066h-.03l.03.595q.023.357.023.732v2.739h-.565v-4.9h.714l2.608 4.054h.03l-.018-.327-.024-.476q-.006-.262-.006-.482v-2.769h.577zM99.678 49.208h-.62v-2.286h-2.512v2.286h-.613v-4.9h.613v2.072h2.512v-2.072h.62zM102.182 50.697h-1.943v-.3l.772-.778q.221-.222.371-.393.154-.175.232-.34.079-.168.079-.364 0-.243-.146-.368-.143-.128-.372-.128-.214 0-.379.075-.16.075-.328.207l-.193-.243q.171-.147.393-.247.225-.1.507-.1.411 0 .65.208.239.207.239.575 0 .228-.096.432-.093.2-.264.396-.168.197-.393.418l-.615.604v.018h1.486z\"/\u003e\u003c/g\u003e\u003cpath stroke=\"#c6c62c\" d=\"m51.124 52.812-5.243-3.027\" class=\"hi\"/\u003e\u003cpath stroke=\"#3050f8\" d=\"m90.277 48.579-5.022 2.899\" class=\"hi\"/\u003e\u003c/g\u003e\u003c/g\u003e\u003c/svg\u003e","Title":"(+)-Modafinil","UNII":"152JRG3T0U"},{"Aliases":["Armodafinil","(R)-Modafinil","(R)-(-)-Modafinil","CEP-10953","armodafinilo","Modafinil, (r)-","R-(-)-Modafinil","armodafinilum","CRL 40982","(-)-(R)-modafinil","2-[(R)-(Diphenylmethyl)sulfinyl]acetamide","CEP 10953","CEP-10952","CRL-40982","(-)-2-((R)-(Diphenylmethyl)sulfinyl)acetamide","Acetamide, 2-((diphenylmethyl)sulfinyl)-, (-)-","2-((R)-(diphenylmethyl)sulfinyl)acetamide","Acetamide, 2-((r)-(diphenylmethyl)sulfinyl)-","R-modafinil","(-)-2-[(r)-(diphenylmethyl)sulfinyl]acetamide","N06BA13","Nuvigil","2-[(r)-benzhydrylsulfinyl]acetamide","l-Modafinil","(-) modafinil"],"PubChemId":9690109,"SMILES":"C1=CC=C(C=C1)C(C2=CC=CC=C2)[S@](=O)CC(=O)N","Structure":"\u003csvg  preserveAspectRatio=\"none\" style=\"display:block\" viewBox=\"0 0 102.742 78.285\"\u003e\u003crect width=\"100%\" height=\"100%\" fill=\"#fff\"/\u003e\u003cdesc\u003eGenerated by the Chemistry Development Kit (http://github.com/cdk)\u003c/desc\u003e\u003cg fill=\"#3050f8\" stroke=\"#000\" stroke-linecap=\"round\" stroke-linejoin=\"round\" stroke-width=\".7\"\u003e\u003cpath fill=\"#fff\" stroke=\"none\" d=\"M0 0h103v79H0z\"/\u003e\u003cg class=\"mol\"\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m53.846 8.658-13.208-7.62M51.407 10.066 40.638 3.853\"/\u003e\u003c/g\u003e\u003cpath d=\"M53.846 8.658v15.24\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m40.638 31.518 13.208-7.62M40.638 28.703l10.769-6.213\"/\u003e\u003c/g\u003e\u003cpath d=\"m40.638 31.518-13.208-7.62\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"M27.43 8.658v15.24M29.868 10.066V22.49\"/\u003e\u003c/g\u003e\u003cpath d=\"M40.638 1.038 27.43 8.658M40.638 31.518v15.24M40.638 46.758l-13.198 7.62\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"M27.44 54.378 14.236 46.75M25.002 55.786l-10.766-6.22\"/\u003e\u003c/g\u003e\u003cpath d=\"M14.236 46.75 1.038 54.37\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m1.038 54.37.005 15.248M3.477 55.777l.004 12.434\"/\u003e\u003c/g\u003e\u003cpath d=\"m1.043 69.618 13.203 7.629\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m14.246 77.247 13.198-7.62M14.247 74.431l10.759-6.212\"/\u003e\u003c/g\u003e\u003cpath d=\"m27.44 54.378.004 15.249M40.638 46.758l10.486 6.054\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"M55.055 58.296v7.401M52.617 58.296v7.401\"/\u003e\u003cpath stroke=\"#c6c62c\" d=\"M55.055 58.296v3.7\" class=\"hi\"/\u003e\u003cpath stroke=\"#ff0d0d\" d=\"M55.055 65.697v-3.701\" class=\"hi\"/\u003e\u003cpath stroke=\"#c6c62c\" d=\"M52.617 58.296v3.7\" class=\"hi\"/\u003e\u003cpath stroke=\"#ff0d0d\" d=\"M52.617 65.697v-3.701\" class=\"hi\"/\u003e\u003c/g\u003e\u003cpath fill=\"#000\" stroke=\"none\" d=\"m56.179 52.208.708 1.226 12.747-5.579-2.25-1.299-1.969-1.137z\" class=\"bond\"/\u003e\u003cpath d=\"m67.034 46.758 13.198 7.62\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"M81.452 53.674v12.023M79.013 53.674v12.023\"/\u003e\u003cpath stroke=\"#ff0d0d\" d=\"M81.452 65.697v-6.011M79.013 65.697v-6.011\" class=\"hi\"/\u003e\u003c/g\u003e\u003cpath d=\"m80.232 54.378 10.045-5.799\" class=\"bond\"/\u003e\u003cpath fill=\"#c6c62c\" stroke=\"none\" d=\"M55.381 55.515q0 .649-.476 1.018-.471.363-1.268.363-.417 0-.768-.065-.346-.06-.578-.173v-.589q.244.113.607.202.369.09.762.09.548 0 .828-.215.28-.214.28-.577 0-.238-.108-.399-.101-.167-.351-.31t-.696-.297q-.625-.227-.947-.554-.315-.333-.315-.899 0-.393.196-.667.203-.279.554-.428.357-.155.815-.155.405 0 .739.077.339.072.613.197l-.197.53q-.25-.113-.547-.185-.298-.077-.626-.077-.458 0-.69.196-.232.197-.232.518 0 .244.101.411.107.167.339.297.232.126.631.28.429.155.727.34.297.178.452.434.155.25.155.637\" class=\"atom\"/\u003e\u003cpath fill=\"#ff0d0d\" stroke=\"none\" d=\"M56.095 69.615q0 .756-.256 1.328-.256.565-.756.881-.5.315-1.244.315-.756 0-1.262-.315-.506-.316-.756-.887-.244-.572-.244-1.334 0-.75.244-1.309.25-.566.756-.882.506-.315 1.274-.315.732 0 1.232.315.5.31.756.876.256.565.256 1.327m-3.863 0q0 .923.387 1.459.392.529 1.22.529.839 0 1.22-.529.387-.536.387-1.459 0-.929-.387-1.452-.381-.524-1.208-.524-.834 0-1.226.524-.393.523-.393 1.452M82.492 69.615q0 .756-.256 1.328-.256.565-.756.881-.5.315-1.245.315-.756 0-1.262-.315-.506-.316-.756-.887-.244-.572-.244-1.334 0-.75.244-1.309.25-.566.756-.882.506-.315 1.274-.315.733 0 1.233.315.5.31.756.876.256.565.256 1.327m-3.864 0q0 .923.387 1.459.393.529 1.22.529.84 0 1.221-.529.387-.536.387-1.459 0-.929-.387-1.452-.381-.524-1.209-.524-.833 0-1.226.524-.393.523-.393 1.452\" class=\"atom\"/\u003e\u003cg stroke=\"none\" class=\"atom\"\u003e\u003cpath d=\"M95.371 49.208h-.72l-2.619-4.066h-.03l.03.595q.023.357.023.732v2.739h-.565v-4.9h.714l2.608 4.054h.03l-.018-.327-.024-.476q-.006-.262-.006-.482v-2.769h.577zM99.678 49.208h-.62v-2.286h-2.512v2.286h-.613v-4.9h.613v2.072h2.512v-2.072h.62zM102.182 50.697h-1.943v-.3l.772-.778q.221-.222.371-.393.154-.175.232-.34.079-.168.079-.364 0-.243-.146-.368-.143-.128-.372-.128-.214 0-.379.075-.16.075-.328.207l-.193-.243q.171-.147.393-.247.225-.1.507-.1.411 0 .65.208.239.207.239.575 0 .228-.096.432-.093.2-.264.396-.168.197-.393.418l-.615.604v.018h1.486z\"/\u003e\u003c/g\u003e\u003cpath stroke=\"#c6c62c\" d=\"m51.124 52.812-5.243-3.027\" class=\"hi\"/\u003e\u003cpath stroke=\"#3050f8\" d=\"m90.277 48.579-5.022 2.899\" class=\"hi\"/\u003e\u003c/g\u003e\u003c/g\u003e\u003c/svg\u003e","Title":"(-)-Modafinil","UNII":"V63XWA605I"},{"Aliases":["Modafinil","modafinil","2-(Benzhydrylsulfinyl)acetamide","modaphonil","Modafinilo","Modafinilum","Modafinil civ","CEP 1538","CEP-1538","Acetamide, 2-((diphenylmethyl)sulfinyl)-","Thn102 component modafinil","DEP-1538","Thn-102 component modafinil","CRC-40476","N06BA07","(rs)-2-(diphenylmethylsulfinyl)acetamide","rac-2-((diphenylmethyl)sulfinyl)acetamide","Provigil","Modiodal","2-[(diphenylmethyl)sulfinyl]acetamide","CRL 40476","Alertec","R Modafinil","CRL-40476","2-((Diphenylmethyl)sulfinyl)acetamide"],"PubChemId":4236,"SMILES":"C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N","Structure":null,"Title":null,"UNII":"R3UK8X3U3D"}],"Stereoisomers":["(+)-Modafinil","(-)-Modafinil","Modafinil"],"Structure":"\u003csvg  preserveAspectRatio=\"none\" style=\"display:block\" viewBox=\"0 0 102.742 78.285\"\u003e\u003crect width=\"100%\" height=\"100%\" fill=\"#fff\"/\u003e\u003cdesc\u003eGenerated by the Chemistry Development Kit (http://github.com/cdk)\u003c/desc\u003e\u003cg fill=\"#3050f8\" stroke=\"#000\" stroke-linecap=\"round\" stroke-linejoin=\"round\" stroke-width=\".7\"\u003e\u003cpath fill=\"#fff\" stroke=\"none\" d=\"M0 0h103v79H0z\"/\u003e\u003cg class=\"mol\"\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m53.846 8.658-13.208-7.62M51.407 10.066 40.638 3.853\"/\u003e\u003c/g\u003e\u003cpath d=\"M53.846 8.658v15.24\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m40.638 31.518 13.208-7.62M40.638 28.703l10.769-6.213\"/\u003e\u003c/g\u003e\u003cpath d=\"m40.638 31.518-13.208-7.62\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"M27.43 8.658v15.24M29.868 10.066V22.49\"/\u003e\u003c/g\u003e\u003cpath d=\"M40.638 1.038 27.43 8.658M40.638 31.518v15.24M40.638 46.758l-13.198 7.62\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"M27.44 54.378 14.236 46.75M25.002 55.786l-10.766-6.22\"/\u003e\u003c/g\u003e\u003cpath d=\"M14.236 46.75 1.038 54.37\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m1.038 54.37.005 15.248M3.477 55.777l.004 12.434\"/\u003e\u003c/g\u003e\u003cpath d=\"m1.043 69.618 13.203 7.629\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m14.246 77.247 13.198-7.62M14.247 74.431l10.759-6.212\"/\u003e\u003c/g\u003e\u003cpath d=\"m27.44 54.378.004 15.249M40.638 46.758l10.486 6.054\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"M55.055 58.296v7.401M52.617 58.296v7.401\"/\u003e\u003cpath stroke=\"#c6c62c\" d=\"M55.055 58.296v3.7\" class=\"hi\"/\u003e\u003cpath stroke=\"#ff0d0d\" d=\"M55.055 65.697v-3.701\" class=\"hi\"/\u003e\u003cpath stroke=\"#c6c62c\" d=\"M52.617 58.296v3.7\" class=\"hi\"/\u003e\u003cpath stroke=\"#ff0d0d\" d=\"M52.617 65.697v-3.701\" class=\"hi\"/\u003e\u003c/g\u003e\u003cpath d=\"m56.533 52.821 10.501-6.063M67.034 46.758l13.198 7.62\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"M81.452 53.674v12.023M79.013 53.674v12.023\"/\u003e\u003cpath stroke=\"#ff0d0d\" d=\"M81.452 65.697v-6.011M79.013 65.697v-6.011\" class=\"hi\"/\u003e\u003c/g\u003e\u003cpath d=\"m80.232 54.378 10.045-5.799\" class=\"bond\"/\u003e\u003cpath fill=\"#c6c62c\" stroke=\"none\" d=\"M55.381 55.515q0 .649-.476 1.018-.471.363-1.268.363-.417 0-.768-.065-.346-.06-.578-.173v-.589q.244.113.607.202.369.09.762.09.548 0 .828-.215.28-.214.28-.577 0-.238-.108-.399-.101-.167-.351-.31t-.696-.297q-.625-.227-.947-.554-.315-.333-.315-.899 0-.393.196-.667.203-.279.554-.428.357-.155.815-.155.405 0 .739.077.339.072.613.197l-.197.53q-.25-.113-.547-.185-.298-.077-.626-.077-.458 0-.69.196-.232.197-.232.518 0 .244.101.411.107.167.339.297.232.126.631.28.429.155.727.34.297.178.452.434.155.25.155.637\" class=\"atom\"/\u003e\u003cpath fill=\"#ff0d0d\" stroke=\"none\" d=\"M56.095 69.615q0 .756-.256 1.328-.256.565-.756.881-.5.315-1.244.315-.756 0-1.262-.315-.506-.316-.756-.887-.244-.572-.244-1.334 0-.75.244-1.309.25-.566.756-.882.506-.315 1.274-.315.732 0 1.232.315.5.31.756.876.256.565.256 1.327m-3.863 0q0 .923.387 1.459.392.529 1.22.529.839 0 1.22-.529.387-.536.387-1.459 0-.929-.387-1.452-.381-.524-1.208-.524-.834 0-1.226.524-.393.523-.393 1.452M82.492 69.615q0 .756-.256 1.328-.256.565-.756.881-.5.315-1.245.315-.756 0-1.262-.315-.506-.316-.756-.887-.244-.572-.244-1.334 0-.75.244-1.309.25-.566.756-.882.506-.315 1.274-.315.733 0 1.233.315.5.31.756.876.256.565.256 1.327m-3.864 0q0 .923.387 1.459.393.529 1.22.529.84 0 1.221-.529.387-.536.387-1.459 0-.929-.387-1.452-.381-.524-1.209-.524-.833 0-1.226.524-.393.523-.393 1.452\" class=\"atom\"/\u003e\u003cg stroke=\"none\" class=\"atom\"\u003e\u003cpath d=\"M95.371 49.208h-.72l-2.619-4.066h-.03l.03.595q.023.357.023.732v2.739h-.565v-4.9h.714l2.608 4.054h.03l-.018-.327-.024-.476q-.006-.262-.006-.482v-2.769h.577zM99.678 49.208h-.62v-2.286h-2.512v2.286h-.613v-4.9h.613v2.072h2.512v-2.072h.62zM102.182 50.697h-1.943v-.3l.772-.778q.221-.222.371-.393.154-.175.232-.34.079-.168.079-.364 0-.243-.146-.368-.143-.128-.372-.128-.214 0-.379.075-.16.075-.328.207l-.193-.243q.171-.147.393-.247.225-.1.507-.1.411 0 .65.208.239.207.239.575 0 .228-.096.432-.093.2-.264.396-.168.197-.393.418l-.615.604v.018h1.486z\"/\u003e\u003c/g\u003e\u003cpath stroke=\"#c6c62c\" d=\"m51.124 52.812-5.243-3.027M56.533 52.821l5.251-3.031\" class=\"hi\"/\u003e\u003cpath stroke=\"#3050f8\" d=\"m90.277 48.579-5.022 2.899\" class=\"hi\"/\u003e\u003c/g\u003e\u003c/g\u003e\u003c/svg\u003e","StructureBase64":"<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" height="78.285mm" version="1.2" viewBox="0 0 102.742 78.285" width="102.742mm">
      
    <desc>Generated by the Chemistry Development Kit (http://github.com/cdk)</desc>
      
    <g fill="#3050F8" stroke="#000000" stroke-linecap="round" stroke-linejoin="round" stroke-width=".7">
            
        <rect fill="#FFFFFF" height="79.0" stroke="none" width="103.0" x=".0" y=".0"/>
            
        <g class="mol" id="mol1">
                  
            <g class="bond" id="mol1bnd1">
                        
                <line x1="53.846" x2="40.638" y1="8.658" y2="1.038"/>
                        
                <line x1="51.407" x2="40.638" y1="10.066" y2="3.853"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd2" x1="53.846" x2="53.846" y1="8.658" y2="23.898"/>
                  
            <g class="bond" id="mol1bnd3">
                        
                <line x1="40.638" x2="53.846" y1="31.518" y2="23.898"/>
                        
                <line x1="40.638" x2="51.407" y1="28.703" y2="22.49"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd4" x1="40.638" x2="27.43" y1="31.518" y2="23.898"/>
                  
            <g class="bond" id="mol1bnd5">
                        
                <line x1="27.43" x2="27.43" y1="8.658" y2="23.898"/>
                        
                <line x1="29.868" x2="29.868" y1="10.066" y2="22.49"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd6" x1="40.638" x2="27.43" y1="1.038" y2="8.658"/>
                  
            <line class="bond" id="mol1bnd7" x1="40.638" x2="40.638" y1="31.518" y2="46.758"/>
                  
            <line class="bond" id="mol1bnd8" x1="40.638" x2="27.44" y1="46.758" y2="54.378"/>
                  
            <g class="bond" id="mol1bnd9">
                        
                <line x1="27.44" x2="14.236" y1="54.378" y2="46.75"/>
                        
                <line x1="25.002" x2="14.236" y1="55.786" y2="49.566"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd10" x1="14.236" x2="1.038" y1="46.75" y2="54.37"/>
                  
            <g class="bond" id="mol1bnd11">
                        
                <line x1="1.038" x2="1.043" y1="54.37" y2="69.618"/>
                        
                <line x1="3.477" x2="3.481" y1="55.777" y2="68.211"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd12" x1="1.043" x2="14.246" y1="69.618" y2="77.247"/>
                  
            <g class="bond" id="mol1bnd13">
                        
                <line x1="14.246" x2="27.444" y1="77.247" y2="69.627"/>
                        
                <line x1="14.247" x2="25.006" y1="74.431" y2="68.219"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd14" x1="27.44" x2="27.444" y1="54.378" y2="69.627"/>
                  
            <line class="bond" id="mol1bnd15" x1="40.638" x2="51.124" y1="46.758" y2="52.812"/>
                  
            <g class="bond" id="mol1bnd16">
                        
                <line x1="55.055" x2="55.055" y1="58.296" y2="65.697"/>
                        
                <line x1="52.617" x2="52.617" y1="58.296" y2="65.697"/>
                      
                <line class="hi" stroke="#C6C62C" x1="55.055" x2="55.055" y1="58.296" y2="61.9965"/>
                <line class="hi" stroke="#FF0D0D" x1="55.055" x2="55.055" y1="65.697" y2="61.9965"/>
                <line class="hi" stroke="#C6C62C" x1="52.617" x2="52.617" y1="58.296" y2="61.9965"/>
                <line class="hi" stroke="#FF0D0D" x1="52.617" x2="52.617" y1="65.697" y2="61.9965"/>
            </g>
                  
            <line class="bond" id="mol1bnd17" x1="56.533" x2="67.034" y1="52.821" y2="46.758"/>
                  
            <line class="bond" id="mol1bnd18" x1="67.034" x2="80.232" y1="46.758" y2="54.378"/>
                  
            <g class="bond" id="mol1bnd19">
                        
                <line x1="81.452" x2="81.452" y1="53.674" y2="65.697"/>
                        
                <line x1="79.013" x2="79.013" y1="53.674" y2="65.697"/>
                      
                <line class="hi" stroke="#FF0D0D" x1="81.452" x2="81.452" y1="65.697" y2="59.685500000000005"/>
                <line class="hi" stroke="#FF0D0D" x1="79.013" x2="79.013" y1="65.697" y2="59.685500000000005"/>
            </g>
                  
            <line class="bond" id="mol1bnd20" x1="80.232" x2="90.277" y1="54.378" y2="48.579"/>
                  
            <path class="atom" d="M55.381 55.515q-.0 .649 -.476 1.018q-.471 .363 -1.268 .363q-.417 .0 -.768 -.065q-.346 -.06 -.578 -.173v-.589q.244 .113 .607 .202q.369 .09 .762 .09q.548 -.0 .828 -.215q.28 -.214 .28 -.577q-.0 -.238 -.108 -.399q-.101 -.167 -.351 -.31q-.25 -.143 -.696 -.297q-.625 -.227 -.947 -.554q-.315 -.333 -.315 -.899q-.0 -.393 .196 -.667q.203 -.279 .554 -.428q.357 -.155 .815 -.155q.405 -.0 .739 .077q.339 .072 .613 .197l-.197 .53q-.25 -.113 -.547 -.185q-.298 -.077 -.626 -.077q-.458 -.0 -.69 .196q-.232 .197 -.232 .518q-.0 .244 .101 .411q.107 .167 .339 .297q.232 .126 .631 .28q.429 .155 .727 .34q.297 .178 .452 .434q.155 .25 .155 .637z" fill="#C6C62C" id="mol1atm14" stroke="none"/>
                  
            <path class="atom" d="M56.095 69.615q.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.244 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q-.0 -.75 .244 -1.309q.25 -.566 .756 -.882q.506 -.315 1.274 -.315q.732 -.0 1.232 .315q.5 .31 .756 .876q.256 .565 .256 1.327zM52.232 69.615q-.0 .923 .387 1.459q.392 .529 1.22 .529q.839 .0 1.22 -.529q.387 -.536 .387 -1.459q.0 -.929 -.387 -1.452q-.381 -.524 -1.208 -.524q-.834 -.0 -1.226 .524q-.393 .523 -.393 1.452z" fill="#FF0D0D" id="mol1atm15" stroke="none"/>
                  
            <path class="atom" d="M82.492 69.615q-.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.245 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q.0 -.75 .244 -1.309q.25 -.566 .756 -.882q.506 -.315 1.274 -.315q.733 -.0 1.233 .315q.5 .31 .756 .876q.256 .565 .256 1.327zM78.628 69.615q.0 .923 .387 1.459q.393 .529 1.22 .529q.84 .0 1.221 -.529q.387 -.536 .387 -1.459q-.0 -.929 -.387 -1.452q-.381 -.524 -1.209 -.524q-.833 -.0 -1.226 .524q-.393 .523 -.393 1.452z" fill="#FF0D0D" id="mol1atm18" stroke="none"/>
                  
            <g class="atom" id="mol1atm19">
                        
                <path d="M95.371 49.208h-.72l-2.619 -4.066h-.03q.012 .238 .03 .595q.023 .357 .023 .732v2.739h-.565v-4.9h.714l2.608 4.054h.03q-.006 -.107 -.018 -.327q-.012 -.22 -.024 -.476q-.006 -.262 -.006 -.482v-2.769h.577v4.9z" stroke="none"/>
                        
                <path d="M99.678 49.208h-.62v-2.286h-2.512v2.286h-.613v-4.9h.613v2.072h2.512v-2.072h.62v4.9z" stroke="none"/>
                        
                <path d="M102.182 50.697h-1.943v-.3l.772 -.778q.221 -.222 .371 -.393q.154 -.175 .232 -.34q.079 -.168 .079 -.364q-.0 -.243 -.146 -.368q-.143 -.128 -.372 -.128q-.214 -.0 -.379 .075q-.16 .075 -.328 .207l-.193 -.243q.171 -.147 .393 -.247q.225 -.1 .507 -.1q.411 .0 .65 .208q.239 .207 .239 .575q.0 .228 -.096 .432q-.093 .2 -.264 .396q-.168 .197 -.393 .418l-.615 .604v.018h1.486v.328z" stroke="none"/>
                      
            </g>
                
            <line class="hi" id="mol1bnd15" stroke="#C6C62C" x1="51.124" x2="45.881" y1="52.812" y2="49.785"/>
            <line class="hi" id="mol1bnd17" stroke="#C6C62C" x1="56.533" x2="61.783500000000004" y1="52.821" y2="49.789500000000004"/>
            <line class="hi" id="mol1bnd20" stroke="#3050F8" x1="90.277" x2="85.25450000000001" y1="48.579" y2="51.4785"/>
        </g>
          
    </g>
    
</svg>
","Subjective Effects":null,"Therapeutic Uses":"Modafinil is indicated to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea (OSAHS), or shift work sleep disorder (SWSD). In OSAHS, modafinil is indicated as an adjunct to standard treatment. Continuing efficacy beyond 9 weeks has not been evaluated in placebo-controlled trials. /Included in US product labeling/","Title":"Modafinil","UNII":"R3UK8X3U3D","Wikidata":"Q410441","Wikipedia":"Modafinil","XLogP":1.7}